课题基金 / 基金详情

The Cardiovascular Safety of Varenicline: A Population-Based Cohort Study

The Cardiovascular Safety of Varenicline: A Population-Based Cohort Study
伐尼克兰的心血管安全性：一项基于人群的队列研究
批准号：
239637
负责人：
Filion Kristian B
金额：
$10.54万
依托单位：
CIUSSS de Centre-Ouest-de-l'Ile-de-Montral-Jewish General
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2011
资助国家：
加拿大
项目状态：
已结题
起止时间：
2011-09-01 至 2013-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=239637&lang=en
关键词：
Cardiovascular Disease Databases Drug Safety Pharmacoepidemiology Side Effects Smoking Cessation Varenicline

项目摘要

项目成果

Filion Kristian B的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Varenicline is a pill that is used to help people quit smoking. It is sold under the trade name Champix. Previous studies have shown that it is the most effective pill used to help people stop smoking. However, there is now some evidence that varenicli
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Comparative Effectiveness of Long-acting Insulins and Neutral Protamine Hagedorn (NPH) Insulin for the Prevention of Micro- and Macrovascular Complications Among Patients with Type 1 Diabetes
The Safety of Antipsychotic Drugs Among Children and Youth With Attention Deficit and Hyperactivity Disorder
Comparative Effectiveness and Safety of Long-acting Insulins and Neutral Protamine Hagedorn (NPH) Insulin among Patients with Type 2 Diabetes
A population-based assessment of pharmacological treatments for gestational diabetes
海外基金